Status: current, Defined. Date: 31-Aug 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3574631000168119 | Candesartan Cilexetil HCT 32/12.5 (Pharmacor) (candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3574641000168111 | Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 627531000036119 | Candesartan Cilexetil HCT 32/12.5 (Pharmacor) (candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg) uncoated tablet (trade product unit of use) | en | Fully specified name | Inactive | Case sensitive | Australian Medicines Terminology module |
| 627541000036112 | Candesartan Cilexetil HCT 32/12.5 (Pharmacor) uncoated tablet | en | Synonym | Inactive | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | Is a | Candesartan Cilexetil HCT 32/12.5 (Pharmacor) | true | Inferred relationship | Some | ||
| Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | Is a | candesartan cilexetil 32 mg + hydrochlorothiazide 12.5 mg tablet | true | Inferred relationship | Some | ||
| Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | has manufactured dose form | uncoated tablet | false | Inferred relationship | Some | ||
| Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | has Australian BoSS | candesartan cilexetil | true | Inferred relationship | Some | 474412301 | |
| Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | has intended active ingredient | candesartan | true | Inferred relationship | Some | 474412301 | |
| Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | has unit of use | tablet | true | Inferred relationship | Some | 895471351 | |
| Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | has intended active ingredient | hydrochlorothiazide | true | Inferred relationship | Some | 895471350 | |
| Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | has Australian BoSS | hydrochlorothiazide | true | Inferred relationship | Some | 895471350 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet, 30 | has TPUU | True | Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | Inferred relationship | Some | 1 |
| Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet, 30, bottle | has TPUU | True | Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | Inferred relationship | Some | 1 |
| Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet, 30, blister pack | has TPUU | True | Candesartan Cilexetil HCT 32/12.5 (Pharmacor) tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR